Ostocin0.025% w/w

Ostocin 0.025% w/w is indicatd for- Rheumatoid arthritis, Osteoarthritis, Pain due to diabetic neuropathy, Joint pain, Post-herpetic neuralgia, Post-surgical neuropathic pain, Nerve Pain, Back pain, Muscle pain, Fibromyalgia, Bursitis, Pruritis (itching)

Topical Analgesics, Topical anti-inflammatory preparations

Although the precise mechanism of action of Ostocin 0.025% w/w is not fully understood, current evidence suggests that Ostocin 0.025% w/w exerts an analgesic effect by depleting and preventing reaccumulation of Substance P in peripheral sensory neurons. Substance P is thought to be the principal chemomediator of pain impulses from the periphery to the central nervous system.

18 years of age and older: Apply a thin film of Ostocin 0.025% w/w cream to affected area 3 to 4 times daily. A burning sensation may occur upon application, but generally disappears with regular use. Application schedules of 3 to 4 times a day for 2 weeks provides optimum pain relief.

18 years of age and older: Apply a thin film of Ostocin 0.025% w/w cream to affected area 3 to 4 times daily. A burning sensation may occur upon application, but generally disappears with regular use. Application schedules of 3 to 4 times a day for 2 weeks provides optimum pain relief.

Ostocin 0.025% w/w cream is contraindicated on broken or irritated skin. It is also contraindicated in patients with known hypersensitivity to Ostocin 0.025% w/w or any of the excipients used in this product.

Ostocin 0.025% w/w may cause transient burning on application. This burning is observed more frequently when the application schedules are more than 3-4 times daily. The burning can be enhanced if too much cream is used and if it is applied just before or after a bath or shower.

The safety of Ostocin 0.025% w/w during pregnancy or lactation has not been established in either humans or animals.

Ostocin 0.025% w/w cream should not be applied to broken or irritated skin. Applied area should not be tightly bandaged. Do not get on mucous membranes and into eyes or on contact lenses. If this occurs, rinse the affected area thoroughly with water. Do not apply the cream on the heat treated area as this may increase the burning sensation. In case of accidental ingestion, seek physician advice immediately.

Sufficient information on overdose of Ostocin 0.025% w/w is not available.

Keep at cool and dry place, away form light. Keep out of the reach of children.

Topical Analgesics, Topical anti-inflammatory preparations

Although the precise mechanism of action of Ostocin 0.025% w/w is not fully understood, current evidence suggests that Ostocin 0.025% w/w exerts an analgesic effect by depleting and preventing reaccumulation of Substance P in peripheral sensory neurons. Substance P is thought to be the principal chemomediator of pain impulses from the periphery to the central nervous system.

The safety of Ostocin 0.025% w/w during pregnancy or lactation has not been established in either humans or animals.